Dear [medical expert],
Are you planning to attend the 2023 CMSC
Annual Meeting? The Novartis team will be
there, and we hope you’ll join us!
Join our symposium to discover Novartis’
commitment to multiple sclerosis.
Medical Directors, Jason Freeman, MD, Stephen
Yeung, DO, and Brandon Brown, PharmD, from
Novartis Neuroscience Medical Affairs will
discuss Novartis' commitment to multiple
sclerosis (MS), that will highlight biomarkers
and their role in monitoring MS disease
activity and BTK and the rationale for
potential therapeutic targeting in MS
Date: Friday, June
2nd
Time: 12:30
PM to 1:30
PM MT
Location: Gaylord Rockies
Resort & Convention Center in Aurora
Exhibit Hall 1-3
We hope to see you there!
|
|
This symposium is neither sponsored nor
endorsed by the Consortium of Multiple
Sclerosis Centers.
Novartis Pharmaceuticals Corporation (NPC)
may not be able to offer you food or
beverages if you are licensed by a state
with a meal limit or prohibition, if you
are a government employee or member of a
formulary committee, or if your
institution or affiliation prohibits your
acceptance of a meal from a pharmaceutical
industry representative. NPC relies on you
to ensure mutual compliance with all
applicable laws and policies.
|
|
|
|